Medical Technology Caucus
This article was originally published in The Gray Sheet
Executive Summary
Holding briefing March 21 to discuss the effects on medical technology of each of the major health care proposals currently before Congress. Clifton Gaus of the Agency for Health Policy Research and Kathleen Buto of the Health Care Financing Administration will represent the Clinton plan; David Kehl, legislative director for Rep. Bob Michel (R-Ill.) will speak for the Republican Action Now plan; and William Schulyer, legislative assistant for Sen. Dave Durenburger (R-Minn.), will represent the Cooper/Breaux plan. Representatives of the Nickles/Sterns, McDermott/Wellstone, Chafee, and Stark plans have been invited as wel
You may also be interested in...
Ultrahuman Expands Wearable Medtech Production Into US After $35M Funding Round
Firm operating in London, India and United Arab Emirates says its “Ultra Factory” will open in Indiana within the next six months with end-to-end production based on its operational facility in India.
Cochlear’s Osia System Receives Expanded FDA Clearance For Use In Younger Children
Kids ages 5 and up now can benefit from Cochlear’s Osia implant and sound processor, indicated for hearing loss, mixed hearing loss and single-sided sensorineural deafness.
MAISI: Navigating The 'Valley Of Death' In Medtech Research Translation
Translating research from proof of concept to clinical investigations is a difficult hurdle to overcome. To succeed, researchers need to design their technology for industrial standard manufacturing early on, Anne Vanhoestenberghe, director for the Manufacture of Active Implants and Surgical Instruments (MAISI), told Medtech Insight.